| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 17.094 | 24.231 | 39.248 | 61.561 | 75.824 | 87.412 | 126.760 |
| Total Income - EUR | - | - | - | 17.094 | 24.231 | 39.248 | 61.580 | 75.824 | 87.412 | 126.762 |
| Total Expenses - EUR | - | - | - | 6.606 | 7.542 | 7.261 | 7.839 | 11.752 | 21.751 | 25.113 |
| Gross Profit/Loss - EUR | - | - | - | 10.488 | 16.689 | 31.988 | 53.741 | 64.072 | 65.660 | 101.649 |
| Net Profit/Loss - EUR | - | - | - | 9.975 | 15.961 | 30.901 | 51.894 | 62.250 | 64.804 | 97.923 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Endosolv S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 2.077 | 1.338 | 1.629 | 1.306 | 7.085 | 5.114 | 4.036 |
| Current Assets | - | - | - | 8.567 | 17.188 | 46.026 | 97.038 | 62.726 | 62.416 | 151.690 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 27 | 0 |
| Receivables | - | - | - | 715 | 2.967 | 2.523 | 4.192 | 2.287 | 8.498 | 62.245 |
| Cash | - | - | - | 7.852 | 14.221 | 43.502 | 92.847 | 60.440 | 53.892 | 89.445 |
| Shareholders Funds | - | - | - | 10.018 | 16.012 | 46.609 | 97.469 | 62.299 | 64.852 | 97.971 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 780 | 2.752 | 1.191 | 1.017 | 7.654 | 3.483 | 58.382 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endosolv S.r.l.